Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Align-Rite Int'l (MASK) Undervalued compared to PLAB DPMI -- Ignore unavailable to you. Want to Upgrade?

To: Douglas V. Fant who wrote (334)	5/24/1999 10:54:00 AM
From: jsabelko	Read Replies (1) \| Respond to of 388

R&D question I've considered owning MASK in the past but always decided against it due to their lack of R&D spending relative to PLAB and DPMI. Last quarter mask spent roughly 2% of revs ($250,000) on R&D vs. plab and dpmi at roughly 5-6% (4-5 million). Are some of mask's r&d costs being effectively hidden by accounting and if not how can they have any hope of keeping up with plab and dpmi? joby sabelko